Skip to main content

Table 3 Performance of SVM prediction models

From: Prediction of early improvement of major depressive disorder to antidepressant medication in adolescents with radiomics analysis after ComBat harmonization based on multiscale structural MRI

Models

AUC (95% CI)

Sensitivity (%)

Specificity (%)

Accuracy (%)

Model based on conventional indicators

SSRIs improver - ADM non-improver

0.776(0.684, 0.853)

64.3(57.5, 71.9)

79.5(69.8, 82.0)

65.3(60.5, 76.8)

SNRIs improver - ADM non-improver

0.796(0.688, 0.882)

72.4(60.1, 79.9)

85.0(70.2, 89.7)

73.0(62.5, 86.1)

ADM improver -ADM non-improver

0.799(0.674, 0.872)

74.5(62.5, 83.2)

81.3(69.0, 88.4)

79.3(70.3, 89.4)

Model based on radiomics features

SSRIs improver - ADM non-improver

0.954(0.912, 0.980)

89.2(78.8, 95.2)

87.4(79.4, 93.1)

88.5(82.4, 92.5)

SNRIs improver - ADM non-improver

0.942(0.897, 0.971)

91.9(83.2, 96.6)

82.5(73.8, 89.3)

86.8(80.5, 91.1)

ADM improver -ADM non-improver

0.889(0.798, 0.952)

91.2(76.8, 98.1)

80.1(64.4, 90.9)

85.1(75.0, 92.3)

  1. SVM Support Vector Mechanism, AUC Area Under the Curve, CI Confidence Interval, MDD Major Depressive Disorder, SSRIs Selective Serotonin Reuptake Inhibitors, SNRIs Serotonin Norepinephrine Reuptake Inhibitors